496 related articles for article (PubMed ID: 29274869)
1. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.
Drossman DA; Tack J; Ford AC; Szigethy E; Törnblom H; Van Oudenhove L
Gastroenterology; 2018 Mar; 154(4):1140-1171.e1. PubMed ID: 29274869
[TBL] [Abstract][Full Text] [Related]
2. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
3. Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.
Sanger GJ; Wang Y; Hobson A; Broad J
Br J Pharmacol; 2013 Dec; 170(7):1323-32. PubMed ID: 23189978
[TBL] [Abstract][Full Text] [Related]
4. The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs.
Olden KW
CNS Spectr; 2005 Nov; 10(11):891-6. PubMed ID: 16273017
[TBL] [Abstract][Full Text] [Related]
5. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
Konturek PC; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
[TBL] [Abstract][Full Text] [Related]
6. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
7. Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When.
Hanna-Jairala I; Drossman DA
Am J Gastroenterol; 2024 Jul; 119(7):1272-1284. PubMed ID: 38595149
[TBL] [Abstract][Full Text] [Related]
8. Fundamentals of neurogastroenterology: basic science.
Grundy D; Al-Chaer ED; Aziz Q; Collins SM; Ke M; Taché Y; Wood JD
Gastroenterology; 2006 Apr; 130(5):1391-411. PubMed ID: 16678554
[TBL] [Abstract][Full Text] [Related]
9. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders.
Sanger GJ; Lee K
Nat Rev Drug Discov; 2008 Mar; 7(3):241-54. PubMed ID: 18309313
[TBL] [Abstract][Full Text] [Related]
10. The enteric nervous system III: a target for pharmacological treatment.
Hansen MB
Pharmacol Toxicol; 2003 Jul; 93(1):1-13. PubMed ID: 12828568
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system involvement in functional gastrointestinal disorders.
Van Oudenhove L; Demyttenaere K; Tack J; Aziz Q
Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):663-80. PubMed ID: 15324706
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic agents in functional gastrointestinal disorders.
Grover M; Drossman DA
Curr Opin Pharmacol; 2008 Dec; 8(6):715-23. PubMed ID: 18760380
[TBL] [Abstract][Full Text] [Related]
13. Novel aspects of enteric serotonergic signaling in health and brain-gut disease.
Del Colle A; Israelyan N; Gross Margolis K
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G130-G143. PubMed ID: 31682158
[TBL] [Abstract][Full Text] [Related]
14. Central sensitisation in visceral pain disorders.
Moshiree B; Zhou Q; Price DD; Verne GN
Gut; 2006 Jul; 55(7):905-8. PubMed ID: 16766744
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial aspects of the functional gastrointestinal disorders.
Levy RL; Olden KW; Naliboff BD; Bradley LA; Francisconi C; Drossman DA; Creed F
Gastroenterology; 2006 Apr; 130(5):1447-58. PubMed ID: 16678558
[TBL] [Abstract][Full Text] [Related]
16. Neuropathophysiology of functional gastrointestinal disorders.
Wood JD
World J Gastroenterol; 2007 Mar; 13(9):1313-32. PubMed ID: 17457962
[TBL] [Abstract][Full Text] [Related]
17. Perceptions, Definitions, and Therapeutic Interventions for Occasional Constipation: A Rome Working Group Consensus Document.
Brenner DM; Corsetti M; Drossman D; Tack J; Wald A
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):397-412. PubMed ID: 37797905
[TBL] [Abstract][Full Text] [Related]
18. The brain-gut axis in abdominal pain syndromes.
Mayer EA; Tillisch K
Annu Rev Med; 2011; 62():381-96. PubMed ID: 21090962
[TBL] [Abstract][Full Text] [Related]
19. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.
Mayer EA; Tillisch K; Bradesi S
Aliment Pharmacol Ther; 2006 Sep; 24(6):919-33. PubMed ID: 16948804
[TBL] [Abstract][Full Text] [Related]
20. The serotonin signaling system: from basic understanding to drug development for functional GI disorders.
Gershon MD; Tack J
Gastroenterology; 2007 Jan; 132(1):397-414. PubMed ID: 17241888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
